Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients. Nihtyanova et ...
The optimum treatment for patients with membranous lupus nephritis is uncertain. Several therapeutic regimens have been suggested, including corticosteroids plus cyclophosphamide or chlorambucil; ...
Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...
Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...
Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...
Correspondence to Dr Almut G Winterstein, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL 32610, USA; almut{at}ufl.edu Background In 2012, ...
Background: Mycophenolate mofetil (MMF) is a new immunosuppressive agent that effectively controls the intraocular inflammation in adults. Purpose: To assess the efficacy of MMF in uveitis in children ...
Background The effectiveness and safety of sirolimus for the treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) have been shown in some studies. However, a comparison of ...
Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States ...
1 Nephrology Department, Cheikh Anta Diop University of Dakar, Dalal Jamm Hospital, Dakar, Senegal. 2 Nephrology Department, Cheikh Anta Diop University of Dakar, Aristide Le Dantec Hospital, Dakar, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback